Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and raises the price target from $80 to $84.
‘TSMC, UMC Stick To Plans For Price Increases In 2023’ – DigiTimes
IC design houses have failed to negotiate lower foundry quotes for 2023 with TSMC and United Microelectronics (UMC), as both foundries stick to their plans for price increases next year, according to industry sources.
